tris(2-carboxyethyl)phosphine has been researched along with clopidogrel in 1 studies
| Studies (tris(2-carboxyethyl)phosphine) | Trials (tris(2-carboxyethyl)phosphine) | Recent Studies (post-2010) (tris(2-carboxyethyl)phosphine) | Studies (clopidogrel) | Trials (clopidogrel) | Recent Studies (post-2010) (clopidogrel) |
|---|---|---|---|---|---|
| 266 | 1 | 145 | 10,221 | 1,918 | 5,951 |
| Protein | Taxonomy | tris(2-carboxyethyl)phosphine (IC50) | clopidogrel (IC50) |
|---|---|---|---|
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.562 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SH; Bae, SK; Hong, JH; Jang, SM; Kang, HC; Noh, WJ; Park, JB; Yoon, KD | 1 |
1 other study(ies) available for tris(2-carboxyethyl)phosphine and clopidogrel
| Article | Year |
|---|---|
Direct measurement of active thiol metabolite levels of clopidogrel in human plasma using tris(2-carboxyethyl)phosphine as a reducing agent by LC-MS/MS.
Topics: Chromatography, Liquid; Clopidogrel; Humans; Oxidation-Reduction; Phosphines; Sulfhydryl Compounds; Tandem Mass Spectrometry; Ticlopidine | 2013 |